About Consort Medical
Consort Medical is a company based in Hemel Hempstead (United Kingdom) founded in 1946 was acquired by Recipharm in November 2019. The company has 12 employees as of December 31, 2021. Consort Medical has completed 1 acquisition, including Aesica. Consort Medical operates in a competitive market with competitors including Aerami, Beyond Air, Breath Therapeutics, Bespak and Activaero, among others.
- Headquarter Hemel Hempstead, United Kingdom
- Employees 12 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Consort Medical Limited
- Date of Incorporation 22 Mar, 1946
- Jurisdiction KING'S LYNN, NORFOLK, ENGLAND
-
Annual Revenue
$415.33 M (USD)6as on Dec 31, 2018
-
Net Profit
-$241.67 M (USD)-927as on Dec 31, 2020
-
EBITDA
-$257.65 M (USD)-1108as on Dec 31, 2020
-
Latest Funding Round
Not available
- Investors
-
Employee Count
12
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
Recipharm
(Nov 18, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Consort Medical
Detailed funding history for Consort Medical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Consort Medical
Consort Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Recipharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Locked | Locked | Locked |
Investor details for Consort Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Consort Medical
Consort Medical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aesica.
Investment portfolio details for Consort Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Consort Medical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Consort Medical
Detailed financials for Consort Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Consort Medical Comparisons
Peer comparison for Consort Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Consort Medical
Consort Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aerami, Beyond Air, Breath Therapeutics, Bespak and Activaero, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
|
|
| Locked | Locked | Locked |
Developer of device for treating respiratory conditions
|
|
| Locked | Locked | Locked |
Inhalation therapies are developed for severe respiratory orphan diseases.
|
|
| Locked | Locked | Locked |
Respiratory drug delivery devices are developed and manufactured.
|
|
| Locked | Locked | Locked |
Controlled breathing technologies for inhaler devices were developed.
|
|
| Locked | Locked | Locked |
Pulmonary drug delivery solutions are developed using AI-enabled inhalers.
|
Detailed competitors of Consort Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Consort Medical
Complete news archive for Consort Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Consort Medical
Consort Medical was founded in 1946.
Consort Medical is headquartered in Hemel Hempstead, United Kingdom.
As of Dec 31, 2021, the latest employee count at Consort Medical is 12.
Annual revenue of Consort Medical is $415.33M as on Dec 31, 2018.
Consort Medical is a healthcare company that through its subsidiaries is focused on medical device technologies for drug delivery and hospital products for the management of patient airways. Aesica Pharmaceuticals and Bespak are subsidiaries of Consort Medical. Aesica is a pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services. Bespak is a company active in the development and manufacture of drug delivery devices, serving pharmaceutical companies with inhaler and auto-injector technologies and development and manufacturing services.
Consort Medical's top competitors include Beyond Air, Pharmosa Biopharm and Aerami.
Consort Medical has made 1 acquisition, including Aesica.
Consort Medical has 1 investor. Key investors include Recipharm.